ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,401 | 66.26099 | 1 |
female
| 0 | 9 | 252 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
under $11k
| 9 | 26,964 | 16,679.6406 | 17,071 | 16.5 |
black
| 26.796875 | 51 | 0.689941 | 0.5979 | 4 | 1 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 9 | 102 | 6.799805 | 60 | 16 | 38 | null | null | 0.599976 | 1.299805 | 140 | null | 91 | 15 | null | 0 | 6 | null | 6 |
5,402 | 68.88196 | 1 |
male
| 0 | 10 | 334 |
COPD
|
COPD/CHF/Cirrhosis
| 6 | 7 |
under $11k
| 9 | 21,663 | 13,114.1641 | 13,237 | 18.5 |
white
| 18.597656 | 37 | 0.843994 | 0.744995 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 10 | 112 | 5.599609 | 80 | 10 | 36.89844 | 292 | 1.399902 | 1.199951 | 0.599976 | 138 | 7.429688 | 104 | 13 | 1,450 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,403 | 73.79297 | 1 |
female
| 0 | 10 | 16 |
Lung Cancer
|
Cancer
| 1 | 12 | null | 0 | 10,375 | 6,902.6602 | 7,978 | 11.5 |
white
| 22 | 23 | 0.569946 | 0.248993 | 1 | 0 | 0 |
metastatic
| 0.4 | 0.1 |
dnr after sadm
| 4 | 77 | 7.899414 | 95 | 26 | 38.39844 | 78 | 3.399902 | 0.699951 | 1.099854 | 138 | 7.069336 | 130 | 28 | 1,175 | 7 | 3 |
<2 mo. follow-up
| 3 |
5,404 | 52.76898 | 1 |
male
| 0 | 55 | 193 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 | null | 0 | 121,661 | null | null | 23 |
black
| 29.296875 | 77 | 0.68396 | 0.589966 | 41 | 1 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 55 | 154 | 27.398438 | 150 | 36 | 35.79688 | 168.3125 | 2.599609 | 6.799805 | 1.799805 | 146 | 7.319336 | 210 | 60 | 4,670 | 0 | null |
adl>=4 (>=5 if sur)
| 0.494751 |
5,405 | 91.16797 | 0 |
female
| 0 | 6 | 543 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | null |
$11-$25k
| 9 | 7,025 | 4,443.6758 | 6,459 | 8 |
white
| 24 | 44 | 0.567993 | 0.372986 | 1 | 0 | 0 |
no
| null | null |
dnr before sadm
| -1 | 133 | 6.899414 | 135 | 6 | 35.89844 | 300 | null | 0.399963 | 1.199951 | 142 | 7.329102 | 133 | 10 | 1,120 | null | null |
adl>=4 (>=5 if sur)
| 5.06543 |
5,406 | 53.26199 | 1 |
male
| 0 | 4 | 16 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 4,797 | 2,928.8633 | 2,974 | 6 |
white
| 15 | 13 | 0.769897 | 0.522949 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.3 |
no dnr
| 4 | 135 | 10 | 55 | 24 | 35.69531 | 203.3125 | null | 0.699951 | 1.199951 | 150 | 7.469727 | 145 | 11 | 2,749 | null | null |
<2 mo. follow-up
| 1.969238 |
5,407 | 59.73999 | 1 |
female
| 1 | 30 | 30 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 16 | null | 0 | 90,045 | null | null | 28.5 |
white
| 42.195313 | 60 | 0.44696 | 0.244995 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 30 | 60 | 9.798828 | 100 | 8 | 36.19531 | 348.5625 | null | null | 0.699951 | 141 | 7.369141 | 162 | 7 | 1,900 | null | 0 |
<2 mo. follow-up
| 0 |
5,408 | 82.56 | 0 |
male
| 0 | 12 | 541 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 2 |
under $11k
| 0 | 31,745 | 18,582.2031 | 20,927 | 11.5 |
white
| 15.398438 | 17 | 0.859985 | 0.768921 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 12 | 53 | 128.78125 | 150 | 24 | 38.69531 | 242.5 | 2.5 | 2.299805 | 2.399902 | 142 | 7.30957 | 109 | 44 | 260 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,409 | 54.237 | 1 |
male
| 1 | 5 | 5 |
Coma
|
Coma
| 0 | 7 | null | 0 | 36,353 | null | null | 45 |
other
| 37.898438 | 78 | 0.424988 | 0.350952 | 1 | 0 | 0 |
no
| 0.5 | 0.35 |
dnr after sadm
| 5 | 103 | 7.299805 | 60 | 24 | 36.09375 | 185 | 2.5 | 1.599854 | 0.799927 | 134 | 7.359375 | 240 | 8 | 2,080 | null | 1 |
<2 mo. follow-up
| 1 |
5,410 | 65.60699 | 1 |
male
| 1 | 4 | 4 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 8 |
$11-$25k
| 0 | 14,532 | null | null | 31 |
hispanic
| 65.390625 | 100 | 0 | 0 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 63 | 6.599609 | 70 | 16 | 36.69531 | null | 3.599609 | 0.5 | 1.799805 | 135 | null | 73 | 40 | 1,200 | null | null |
<2 mo. follow-up
| 1.799561 |
5,411 | 69.224 | 1 |
male
| 0 | 9 | 104 |
Lung Cancer
|
Cancer
| 1 | 16 | null | 0 | 10,246 | 6,972.5977 | 7,689 | 10 |
white
| 17.199219 | 5 | 0.69397 | 0.403992 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.3 |
no dnr
| 9 | 53 | 7.5 | 68 | 48 | 36.59375 | 168 | null | 0.5 | 0.699951 | 137 | 7.369141 | 85 | 13 | 2,650 | null | 0 |
Coma or Intub
| 0 |
5,412 | 65.28998 | 0 |
female
| 0 | 46 | 538 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
>$50k
| 44 | 198,680 | 116,222.125 | 113,054 | 34.75 |
white
| 25.199219 | 35 | 0.559937 | 0.44696 | 8 | 0 | 0 |
no
| 0.7 | 0.8 |
no dnr
| 46 | 27 | 18.199219 | 180 | 22 | 38.19531 | 243.3125 | null | null | 1.599854 | 142 | 7.30957 | 211 | 26 | 0 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,413 | 73.32196 | 1 |
male
| 0 | 10 | 42 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 24,700 | null | null | 18 |
white
| 18.898438 | 18 | 0.848999 | 0.751953 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 9 | 113 | 6.299805 | 60 | 9 | 38.39844 | 259 | null | null | 1.399902 | 133 | 7.489258 | 102 | 20 | 2,030 | null | null |
<2 mo. follow-up
| 2.810059 |
5,414 | 80.39996 | 1 |
male
| 0 | 10 | 28 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 27,456 | null | null | 26.5 |
white
| 23.398438 | 32 | 0.720947 | 0.565918 | 1 | 0 | 0 |
no
| 0.85 | 0.65 |
no dnr
| 10 | 43 | 45.898438 | 135 | 22 | 38.69531 | 125.45312 | null | 5.199219 | 11.298828 | 136 | 7.339844 | 142 | 111 | 15 | null | 0 |
<2 mo. follow-up
| 0 |
5,415 | 47.97498 | 0 |
male
| 0 | 43 | 536 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 6 | null | 0 | 89,130 | 57,088.8438 | 59,258 | 21.25 |
white
| 16.597656 | 12 | 0.904907 | 0.870972 | 4 | 0 | 0 |
no
| 0.85 | 0.85 |
no dnr
| 43 | 105 | 15 | 105 | 30 | 34.19531 | 297.125 | 3.399902 | 1 | 5.799805 | 140 | 7.279297 | 145 | 53 | 810 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,416 | 57.02899 | 1 |
male
| 0 | 17 | 48 |
Lung Cancer
|
Cancer
| 1 | 0 |
under $11k
| 0 | 16,234 | 10,966.8984 | 12,575 | 5.666664 |
white
| 26.699219 | 22 | 0.494995 | 0.174988 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.15 |
no dnr
| 17 | 120 | 3 | 115 | 10 | 38.5 | 167.5 | 3.299805 | 2.599609 | 0.899902 | 146 | 7.30957 | 89 | 19 | 2,110 | null | 1 |
<2 mo. follow-up
| 1 |
5,417 | 71.59998 | 1 |
female
| 0 | 7 | 130 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | null |
under $11k
| 0 | 8,299 | 6,645.6406 | 6,728 | 10.5 |
black
| 15.699219 | 10 | 0.884888 | 0.80896 | 1 | 1 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 7 | 62 | 8.798828 | 75 | 28 | 35.29688 | 172.5 | null | null | 1.199951 | 140 | 7.449219 | 123 | 35 | 1,165 | null | 1 | null | 1 |
5,418 | 59.39798 | 0 |
male
| 0 | 20 | 536 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 38,214 | 23,649.0312 | 24,873 | 24.333328 |
white
| 22 | 25 | 0.812988 | 0.75 | 1 | 0 | 0 |
yes
| 0.75 | 0.65 |
no dnr
| 20 | 62 | 13 | 125 | 36 | 39.09375 | 343.3125 | null | 0.5 | 4.699219 | 138 | 7.419922 | 546 | 43 | 1,012 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
5,419 | 85.25397 | 0 |
female
| 0 | 4 | 535 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 10 |
$11-$25k
| 0 | 5,269 | 3,610.668 | 3,689 | 7 |
white
| 19.597656 | 16 | 0.797974 | 0.67395 | 1 | 0 | 0 |
no
| 0.75 | 0.5 |
no dnr
| 4 | 145 | 6.599609 | 60 | 8 | 37.89844 | 283.3125 | 3.099609 | 0.399963 | 1.099854 | 141 | 7.299805 | 258 | 27 | 2,147 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,420 | 66.89398 | 0 |
male
| 0 | 35 | 534 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 15 |
$11-$25k
| 41 | 42,993 | 29,988.3438 | 34,828 | 17.25 |
white
| 29 | 49 | 0.55896 | 0.362976 | 1 | 0 | 0 |
no
| 0.8 | 0.5 |
dnr after sadm
| 5 | 18 | 9.898438 | 35 | 36 | 38.19531 | 195 | null | null | 2.099609 | 137 | 7.449219 | 413 | 52 | 1,065 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,421 | 72.74194 | 1 |
male
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 |
$11-$25k
| 0 | 79,139 | 45,057.0312 | 43,214 | 39.333313 |
white
| 32.796875 | 77 | 0.600952 | 0.493958 | 1 | 0 | 0 |
no
| 0.35 | 0.3 |
dnr after sadm
| 11 | 52 | 0.099991 | 135 | 26 | 36.09375 | 316.625 | 2.599609 | 10.5 | 2.899902 | 143 | 7.299805 | 86 | 90 | 435 | null | 0 |
<2 mo. follow-up
| 0 |
5,422 | 63.92599 | 1 |
male
| 1 | 16 | 16 |
Coma
|
Coma
| 1 | 10 |
under $11k
| 55 | 45,913 | 27,442.4531 | 29,277 | 22.666656 |
white
| 17.5 | 31 | 0.547974 | 0.478943 | 1 | 0 | 0 |
yes
| 0.1 | 0.02 |
dnr after sadm
| 4 | 108 | 18.597656 | 120 | 20 | 35.79688 | 660 | null | null | 0.699951 | 136 | 7.449219 | 156 | 15 | 700 | null | 0 |
<2 mo. follow-up
| 0 |
5,423 | 44.85699 | 1 |
male
| 0 | 14 | 135 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | null |
under $11k
| 100 | 51,906 | 29,462.7344 | 30,650 | 16 |
black
| 28.898438 | 37 | 0.534912 | 0.335999 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 14 | 68 | 8.398438 | 105 | 8 | 35.29688 | 250 | 2.699707 | 0.399963 | 0.599976 | 142 | 7.429688 | 106 | 8 | 5,065 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,424 | 66.54596 | 1 |
female
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 | null | 44 | 147,889 | null | null | 44.25 |
white
| 42 | 77 | 0.102997 | 0.042999 | 1 | 0 | 0 |
yes
| 0.5 | 0.4 |
dnr after sadm
| 24 | 115 | null | 75 | 12 | 36.19531 | 433.3125 | null | null | 1.199951 | 145 | 7.40918 | 178 | 16 | 1,725 | null | 0 |
<2 mo. follow-up
| 0 |
5,425 | 30.10799 | 0 |
female
| 0 | 9 | 532 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 |
$25-$50k
| 0 | null | null | null | 14 |
white
| 22.296875 | 31 | 0.897949 | 0.860962 | 3 | 0 | 0 |
no
| 0.8 | 0.6 | null | null | 30 | 1 | 175 | 35 | 39.09375 | 131.65625 | 3.099609 | 0.299988 | 1.899902 | 153 | 7.149414 | 9 | 52 | 843 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,426 | 64.12 | 0 |
female
| 0 | 14 | 531 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
under $11k
| 0 | 39,588 | 23,305.7969 | 26,626 | 23.333328 |
black
| 37.195313 | 50 | 0.494995 | 0.376953 | 3 | 1 | 0 |
no
| null | null |
no dnr
| 14 | 108 | 12.199219 | 65 | 24 | 38.09375 | 268.5625 | null | 0.799927 | 8.199219 | 129 | 7.439453 | 225 | 39 | 0 | null | 0 |
SIP>=30
| 0 |
5,427 | 65.81799 | 1 |
female
| 0 | 7 | 397 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 7,743 | 5,370.8398 | 6,120 | 6.5 |
white
| 16.898438 | 1 | 0.889893 | 0.816895 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 7 | 128 | 10.798828 | 55 | 8 | 39.09375 | 270 | null | 0.699951 | 1.299805 | 160 | 7.449219 | 153 | 17 | 1,975 | 0 | null |
SIP>=30
| 0.494751 |
5,428 | 69.10297 | 0 |
female
| 0 | 6 | 533 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 16 | null | 0 | 13,926 | 8,603.0234 | 9,492 | 17 |
white
| 16.296875 | 23 | 0.885986 | 0.809937 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 6 | 48 | 12.199219 | 125 | 26 | 36.19531 | 869.375 | null | null | 2.899902 | 158 | 7.30957 | 272 | 79 | 925 | null | null |
no(M2 and SIP pres)
| 2.119141 |
5,429 | 74.58997 | 1 |
male
| 1 | 8 | 8 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 8,683 | 5,717.5 | 6,143 | 12.5 |
white
| 20.699219 | 19 | 0.806885 | 0.688965 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 5 | 112 | 33 | 115 | 38 | 38.09375 | 251.40625 | 2.399902 | 24.398438 | 2 | 145 | 7.459961 | 379 | 121 | 2,330 | 1 | 2 |
<2 mo. follow-up
| 2 |
5,430 | 56.939 | 0 |
female
| 0 | 12 | 532 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
$11-$25k
| 0 | 54,366 | 35,763.0938 | 39,123 | 19 |
black
| 26.796875 | 43 | 0.718994 | 0.631958 | 26 | 0 | 0 |
no
| 1 | 1 |
no dnr
| 12 | 75 | 6.399414 | 95 | 30 | 38 | 348 | 2 | 1.5 | 0.899902 | 147 | 7.489258 | 138 | 22 | 1,010 | null | 3 |
no(M2 and SIP pres)
| 3 |
5,431 | 66.02594 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 20 | null | 0 | 44,230 | 22,836.0156 | 23,455 | 57 |
white
| 40.296875 | 64 | 0.439941 | 0.319946 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 148 | 12.798828 | 105 | 26 | 36.59375 | 232.5 | null | null | 0.699951 | 148 | 7.429688 | 298 | 14 | 2,875 | null | null |
<2 mo. follow-up
| 1.963135 |
5,432 | 41.09 | 1 |
male
| 0 | 5 | 23 |
Lung Cancer
|
Cancer
| 1 | 14 |
$11-$25k
| 0 | 6,703 | 4,328.6406 | 5,094 | 4 |
black
| 23.699219 | 12 | 0.625 | 0.311951 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 75 | 6.099609 | 70 | 16 | 36.29688 | null | 4.099609 | 0.399963 | 0.799927 | 144 | null | 112 | 6 | 7,250 | 0 | null |
<2 mo. follow-up
| 0.494751 |
5,433 | 75.95898 | 1 |
female
| 0 | 14 | 241 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
under $11k
| 9 | 43,724 | 26,366.875 | 26,451 | 24.333328 |
white
| 33.195313 | 38 | 0.324951 | 0.210999 | 5 | 0 | 0 |
yes
| 0.9 | 0.8 |
no dnr
| 14 | 95 | 6.199219 | 70 | 18 | 36.09375 | 323.75 | null | 2.799805 | 1.199951 | 135 | 7.439453 | 68 | 15 | 1,925 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,434 | 52.45999 | 1 |
female
| 1 | 9 | 9 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 14 | null | 41 | 119,149 | 67,033.5 | 64,675 | 43 |
white
| 40.398438 | 73 | 0.081985 | 0.012999 | 21 | 0 | 0 |
no
| 0.4 | 0.2 |
dnr after sadm
| 8 | 68 | 13.099609 | 105 | 32 | 36.69531 | 357.125 | 3 | 0.399963 | 0.899902 | 137 | 7.379883 | 105 | 15 | null | null | 2 |
<2 mo. follow-up
| 2 |
5,435 | 49.71698 | 1 |
female
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 |
under $11k
| 41 | 70,066 | null | null | 53.5 |
white
| 35.195313 | 59 | 0.44397 | 0.324951 | 3 | 0 | 0 |
no
| 0.05 | 0 |
dnr after sadm
| 4 | 138 | 15.298828 | 125 | 20 | 38 | 242 | 2.099609 | 1.199951 | 0.599976 | 132 | 7.279297 | 153 | 12 | 1,915 | null | null |
<2 mo. follow-up
| 2.615723 |
5,436 | 39.32098 | 0 |
male
| 0 | 15 | 529 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 |
under $11k
| 0 | 36,544 | 23,668.5156 | 25,044 | 19 |
black
| 17.597656 | 24 | 0.919922 | 0.889893 | 2 | 0 | 0 |
no
| 1 | 0.9 |
no dnr
| 15 | 53 | 22.898438 | 130 | 24 | 39.19531 | 132 | null | null | 1 | 135 | 7.419922 | 99 | 14 | 1,665 | null | 5 | null | 5 |
5,437 | 67.51495 | 1 |
male
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 98,266 | null | null | 52 |
white
| 47.796875 | 127 | 0.028999 | 0.007 | 20 | 0 | 0 |
yes
| 0 | 0 |
no dnr
| 5 | 97 | 17 | 68 | 20 | 36 | null | 4 | 0.799927 | 0.699951 | 142 | null | 125 | 13 | null | null | null |
<2 mo. follow-up
| 1.925293 |
5,438 | 61.80698 | 1 |
male
| 1 | 14 | 14 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 8 |
under $11k
| 9 | 44,938 | 24,608.9219 | 26,028 | 28 |
white
| 35.09375 | 48 | 0.583984 | 0.391968 | 1 | 0 | 0 |
no
| 0.05 | 0 |
dnr after sadm
| 9 | 115 | 3.099609 | 105 | 12 | 38.39844 | 385.6875 | 2.699707 | 4.399414 | 1 | 131 | 7.449219 | 97 | 10 | 1,235 | null | 1 |
<2 mo. follow-up
| 1 |
5,439 | 56.13397 | 1 |
female
| 1 | 14 | 14 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null |
under $11k
| 44 | 87,450 | 49,439.0625 | 50,099 | 38.333313 |
black
| 38.59375 | 95 | 0.067993 | 0.023998 | 7 | 0 | 0 |
yes
| 0.7 | 0.6 |
dnr after sadm
| 14 | 102 | 23.097656 | 105 | 33 | 36.29688 | 233.3125 | null | 0.799927 | 6.199219 | 133 | 7.379883 | 284 | 105 | 811 | null | 3 |
<2 mo. follow-up
| 3 |
5,440 | 34.34399 | 0 |
female
| 0 | 17 | 528 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
$11-$25k
| 9 | 46,653 | null | null | 23.333328 |
black
| 29.398438 | 57 | 0.810913 | 0.748901 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 17 | 53 | 3.099609 | 115 | 10 | 36.39844 | 302.8125 | 1.399902 | 2.199707 | 0.699951 | 134 | 7.299805 | 81 | 27 | 3,160 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,441 | 55.52597 | 1 |
female
| 0 | 47 | 56 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 92,466 | null | null | 26.25 |
white
| 31.398438 | 60 | 0.7229 | 0.638916 | 1 | 1 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 47 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
5,442 | 52.57999 | 0 |
male
| 0 | 6 | 525 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 6 | null | 9 | 13,753 | 8,494.375 | 9,086 | 12 |
black
| 15.798828 | 11 | 0.893921 | 0.855957 | 3 | 1 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 6 | 58 | 17.398438 | 115 | 16 | 35.79688 | 133.3125 | 0.899902 | 1.699951 | 4.899414 | 137 | 7.319336 | 72 | 60 | 88 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,443 | 69.14996 | 0 |
male
| 0 | 6 | 525 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 3 | null | 0 | 12,983 | 8,177.3086 | 8,862 | 19 |
black
| 26.699219 | 28 | 0.753906 | 0.611938 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 6 | 125 | 17.898438 | 75 | 26 | 36.39844 | 196.65625 | null | null | 1 | 144 | 7.299805 | 512 | 18 | 3,945 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,444 | 51.59497 | 1 |
male
| 1 | 9 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 |
under $11k
| 26 | 43,406 | null | null | 40 |
black
| 78.1875 | 91 | 0 | 0 | 1 | 1 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 9 | 112 | 25 | 95 | 13 | 35.29688 | 356 | null | 14.398438 | 7.699219 | 134 | 7.419922 | 89 | 88 | 200 | null | 3 |
<2 mo. follow-up
| 3 |
5,445 | 65.33099 | 1 |
male
| 1 | 3 | 3 |
Coma
|
Coma
| 0 | 18 |
>$50k
| 100 | 30,271 | 17,778.3438 | 17,836 | 19 |
white
| 65.796875 | 55 | 0 | 0 | 8 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 2 | 123 | 14.798828 | 135 | 40 | 39.09375 | 266.625 | 2.899902 | 1.099854 | 0.699951 | 140 | 7.429688 | 179 | 13 | 4,125 | null | 0 |
<2 mo. follow-up
| 0 |
5,446 | 49.81198 | 1 |
female
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 100 | 17,471 | null | null | 50 |
black
| 51.09375 | 104 | 0.002 | 0 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 3 | 68 | 12.398438 | 115 | 9 | 38.89844 | 331.375 | null | 1.099854 | 5 | 144 | 7.489258 | 210 | 123 | 60 | null | null |
<2 mo. follow-up
| 3.373047 |
5,447 | 58.439 | 1 |
female
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 53,976 | 30,542.7031 | 32,550 | 32 |
white
| 26.796875 | 55 | 0.554932 | 0.441956 | 12 | 0 | 0 |
yes
| 0.3 | 0.1 |
dnr after sadm
| 1 | 107 | 10 | 80 | 28 | 36.29688 | null | 3.099609 | 0.5 | 0.599976 | 130 | null | 248 | 9 | 4,800 | null | null |
<2 mo. follow-up
| 2.542481 |
5,448 | 46.93799 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 0 | null | null | 41 | 80,331 | 45,993.3438 | 44,799 | 45 |
white
| 24.097656 | 32 | 0.584961 | 0.518921 | 9 | 0 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 5 | 124 | 15 | 125 | 30 | 36.19531 | 286.9375 | null | null | 1.699951 | 146 | 7.399414 | 114 | 52 | 875 | null | null |
<2 mo. follow-up
| 1.789063 |
5,449 | 29.782 | 0 |
male
| 0 | 35 | 522 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 165,685 | null | null | 33 |
black
| 25.097656 | 38 | 0.873901 | 0.828979 | 3 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 35 | 100 | 7.299805 | 64 | 32 | 36.59375 | 204.75 | null | null | 0.699951 | 139 | 7.299805 | 159 | 29 | 3,050 | null | null | null | 1.835205 |
5,450 | 71.42499 | 1 |
female
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
$11-$25k
| 41 | 186,564 | 103,832.562 | 95,396 | 43.333313 |
white
| 16.796875 | 26 | 0.720947 | 0.634888 | 12 | 0 | 0 |
no
| null | null |
dnr after sadm
| 22 | 75 | 16.398438 | 112 | 16 | 36.29688 | null | null | 0.599976 | 0.699951 | 135 | null | 111 | 33 | null | null | 7 |
<2 mo. follow-up
| 7 |
5,451 | 55.87097 | 1 |
female
| 1 | 4 | 4 |
Lung Cancer
|
Cancer
| 1 | 12 | null | 0 | 3,932 | 2,679.8769 | 3,388 | 7 |
white
| 30.796875 | 22 | 0.379944 | 0.090988 | 1 | 0 | 0 |
metastatic
| 0 | 0 |
dnr after sadm
| 1 | 55 | 19.5 | 160 | 30 | 38 | 320 | 2.799805 | 0.799927 | 10 | 133 | 7.399414 | 78 | 89 | 200 | null | null |
<2 mo. follow-up
| 2.458984 |
5,452 | 32.43799 | 0 |
female
| 0 | 129 | 519 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 18 |
$11-$25k
| 44 | 440,306 | null | null | 40.25 |
hispanic
| 36.09375 | 64 | 0.564941 | 0.453979 | 1 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 129 | 80 | 13.099609 | 128 | 24 | 36.09375 | 200 | null | null | 1.099854 | 135 | 7.129883 | 227 | 34 | 500 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,453 | 70.64496 | 0 |
female
| 0 | 108 | 519 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 171,148 | null | null | 26.5 |
white
| 26.597656 | 66 | 0.726929 | 0.642944 | 2 | 0 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 6 | 73 | 10.298828 | 75 | 20 | 38.29688 | 452.375 | null | null | 0.699951 | 134 | 7.469727 | 136 | 10 | null | 6 | 6 |
adl>=4 (>=5 if sur)
| 6 |
5,454 | 50.95398 | 1 |
male
| 1 | 41 | 41 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 | null | 0 | 180,519 | null | null | 40 |
white
| 29.898438 | 33 | 0.559937 | 0.44696 | 2 | 0 | 0 |
yes
| 0.5 | 0.3 |
dnr after sadm
| 21 | 40 | 27.5 | 40 | 15 | 35.19531 | 268 | null | 2 | 1.299805 | 129 | 7.509766 | 106 | 20 | 455 | null | 0 |
<2 mo. follow-up
| 0 |
5,455 | 26.09698 | 0 |
female
| 0 | 10 | 517 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 | null | 9 | 25,295 | 16,307.4609 | 18,321 | 16 |
white
| 37.296875 | 69 | 0.713989 | 0.626953 | 1 | 1 | 0 |
no
| 1 | 1 |
dnr after sadm
| 4 | 105 | 9.699219 | 65 | 24 | 37 | 390.4375 | null | null | 1.299805 | 143 | 7.519531 | 107 | 22 | 2,150 | 2 | null |
SIP>=30
| 1.838867 |
5,456 | 67.26099 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 100 | null | null | null | 44 |
white
| 98 | 141 | 0 | 0 | 8 | 0 | 0 |
no
| 0.6 | 0.4 |
dnr after sadm
| 3 | 68 | 5.5 | 115 | 36 | 39.19531 | 82.84375 | 2.399902 | 11.099609 | 1.199951 | 155 | 7.449219 | 400 | 48 | 2,460 | null | 0 |
<2 mo. follow-up
| 0 |
5,457 | 64.66498 | 0 |
male
| 0 | 28 | 516 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 3 |
$11-$25k
| 0 | 85,357 | 51,161.6875 | 54,012 | 22.5 |
other
| 27.296875 | 47 | 0.710938 | 0.623901 | 5 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 28 | 42 | 19.296875 | 65 | 33 | 33.69531 | 34 | 3.299805 | 32.398438 | 7.399414 | 147 | 7.279297 | 102 | 88 | 570 | null | null | null | 2.625 |
5,458 | 31.22499 | 1 |
male
| 0 | 4 | 330 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 |
$25-$50k
| 44 | 27,355 | 16,787.5156 | 17,752 | 17 |
white
| 21.796875 | 27 | 0.791992 | 0.723999 | 10 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 4 | 83 | 8.599609 | 105 | 20 | 36.29688 | null | 3.599609 | 0.5 | 0.899902 | 134 | null | 121 | 14 | null | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,459 | 50.97897 | 1 |
male
| 0 | 14 | 35 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 20,779 | 12,855.9375 | 12,840 | 14.333328 |
white
| 27.699219 | 37 | 0.814941 | 0.699951 | 1 | 0 | 0 |
no
| 0.6 | 0.4 |
no dnr
| 14 | 137 | 13.199219 | 115 | 35 | 39.09375 | 319 | null | null | 0.599976 | 133 | 7.449219 | 160 | 17 | 2,065 | 0 | 2 |
<2 mo. follow-up
| 2 |
5,460 | 60.57797 | 0 |
male
| 0 | 8 | 516 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 10 |
under $11k
| 0 | 8,274 | 5,460.8398 | 5,733 | 13 |
white
| 17.898438 | 25 | 0.891968 | 0.819946 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 8 | 102 | 7.799805 | 70 | 24 | 35.89844 | null | 3.299805 | 2.299805 | 1.199951 | 135 | null | 88 | 18 | 2,600 | 2 | 3 |
no(M2 and SIP pres)
| 3 |
5,461 | 87.29596 | 0 |
female
| 0 | 15 | 515 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 26 | 29,832 | null | null | 21.666656 |
white
| 30.296875 | 53 | 0.450989 | 0.33197 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
dnr after sadm
| 5 | 68 | 17.796875 | 55 | 6 | 36.09375 | 193.3125 | 3.099609 | 0.599976 | 1 | 136 | 7.299805 | 246 | 26 | 1,390 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,462 | 78.70795 | 1 |
male
| 1 | 49 | 49 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 231,581 | null | null | 34.5 |
black
| 35.296875 | 67 | 0.375 | 0.255981 | 20 | 0 | 0 |
no
| null | null |
dnr after sadm
| 46 | 78 | 8.099609 | 75 | 6 | 36.29688 | 200 | null | 0.699951 | 0.699951 | 135 | 7.429688 | 81 | 15 | 2,930 | null | null |
<2 mo. follow-up
| 3.058106 |
5,463 | 41.94897 | 1 |
female
| 0 | 12 | 30 |
Lung Cancer
|
Cancer
| 1 | 12 | null | 0 | 14,354 | 9,377.4453 | 9,969 | 11.5 |
hispanic
| 22.898438 | 25 | 0.639893 | 0.330994 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.1 |
no dnr
| 12 | 105 | 7.199219 | 150 | 22 | 36.59375 | null | 2.899902 | 0.899902 | 0.799927 | 139 | null | 99 | 7 | 2,725 | 0 | 1 |
<2 mo. follow-up
| 1 |
5,464 | 64.94995 | 1 |
male
| 0 | 35 | 337 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 |
>$50k
| 0 | 100,447 | 59,049.2188 | 68,243 | 35 |
white
| 24.199219 | 33 | 0.815918 | 0.700928 | 1 | 1 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 19 | 63 | 6.799805 | 75 | 20 | 36.09375 | 644 | null | null | 1.299805 | 136 | 7.449219 | 63 | 19 | 4,700 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,465 | 85.20197 | 1 |
female
| 0 | 10 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 70,407 | 40,572.1562 | 42,464 | 42.5 |
other
| 53.898438 | 93 | 0.003 | 0 | 9 | 0 | 0 |
yes
| 0.1 | 0.05 |
dnr after sadm
| 3 | 73 | 4.199219 | 55 | 8 | 36 | 226.65625 | 2.299805 | 0.5 | 0.699951 | 141 | 7.379883 | 77 | 16 | 1,175 | null | 7 |
<2 mo. follow-up
| 7 |
5,466 | 33.13599 | 1 |
female
| 1 | 38 | 38 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 10 |
under $11k
| 0 | 187,105 | 109,487.562 | 105,650 | 40.25 |
black
| 37.898438 | 64 | 0.699951 | 0.609985 | 1 | 1 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 1 | 111 | 7.599609 | 50 | 16 | 35.79688 | 210.1875 | null | null | 1 | 138 | 7.439453 | 78 | 14 | 700 | null | 2 |
<2 mo. follow-up
| 2 |
5,467 | 45.55798 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 2 | 12 |
under $11k
| 100 | 24,542 | 14,387.2812 | 16,541 | 27 |
black
| 26 | 66 | 0.342957 | 0.269958 | 1 | 1 | 0 |
no
| 0.1 | 0.05 |
dnr after sadm
| 5 | 52 | 10.798828 | 105 | 26 | 40 | 210 | 3.399902 | 0.799927 | 1.699951 | 141 | 7.439453 | 100 | 66 | 1,210 | null | 1 |
<2 mo. follow-up
| 1 |
5,468 | 61.32199 | 0 |
male
| 0 | 4 | 514 |
Lung Cancer
|
Cancer
| 1 | 16 |
$25-$50k
| 0 | 12,236 | 5,965.6328 | 6,239 | 11 |
white
| 14.898438 | 5 | 0.753906 | 0.497986 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 4 | 58 | 23.597656 | 135 | 20 | 38.59375 | 98 | 2.099609 | 1 | 2 | 139 | 7.40918 | 206 | 73 | 1,030 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,469 | 57.50598 | 0 |
female
| 0 | 17 | 512 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 37 | 99,616 | 56,783.5312 | 57,308 | 28.666656 |
white
| 27.597656 | 65 | 0.582886 | 0.472961 | 7 | 0 | 0 |
no
| null | null |
no dnr
| 17 | 118 | 7.099609 | 125 | 9 | 38.29688 | 240 | null | null | 0.899902 | 140 | 7.589844 | 96 | 28 | 1,220 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,470 | 72.68994 | 0 |
female
| 0 | 17 | 512 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 | null | 9 | 84,148 | null | null | 25.666656 |
white
| 22.199219 | 44 | 0.715942 | 0.628906 | 14 | 1 | 0 |
no
| null | null |
no dnr
| 17 | 63 | 14.099609 | 55 | 6 | 35.5 | 214.28125 | 2.5 | 2.599609 | 0.899902 | 143 | 7.369141 | 314 | 28 | 620 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,471 | 69.44299 | 0 |
female
| 0 | 97 | 511 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 11 |
$25-$50k
| 44 | 207,500 | null | null | 28.25 |
white
| 17.398438 | 49 | 0.773926 | 0.701904 | 1 | 1 | 1 |
no
| 0.5 | 0.5 |
no dnr
| 97 | 108 | 30.699219 | 135 | 16 | 37.09375 | 106.65625 | 2.399902 | 13.199219 | 5.399414 | 139 | 7.349609 | 99 | 142 | 431 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
5,472 | 27.29399 | 0 |
female
| 0 | 12 | 510 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 37 | 43,502 | 27,744.9219 | 28,170 | 20 |
black
| 20.699219 | 17 | 0.848999 | 0.796997 | 5 | 0 | 0 |
no
| null | null |
no dnr
| 12 | 122 | 15.699219 | 120 | 24 | 37.59375 | 193.3125 | null | 0.5 | 1.299805 | 136 | 7.489258 | 94 | 23 | 2,940 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,473 | 54.75198 | 0 |
male
| 0 | 18 | 510 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$11-$25k
| 0 | 49,333 | 29,308.0625 | 32,056 | 26.333328 |
black
| 17.296875 | 12 | 0.895996 | 0.858887 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 18 | 108 | 12.5 | 75 | 30 | 35.5 | 146.65625 | null | null | 5 | 125 | 7.389648 | 351 | 74 | 1,350 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,474 | 67.27997 | 0 |
male
| 0 | 11 | 509 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 44 | 25,244 | null | null | 29 |
white
| 35.195313 | 38 | 0.35199 | 0.234985 | 1 | 0 | 1 |
no
| 0.6 | 0.6 |
no dnr
| 11 | 80 | 10.599609 | 80 | 20 | 36.59375 | 420 | null | 0.399963 | 0.5 | 137 | 7.389648 | 184 | 7 | 2,600 | null | null | null | 5.219727 |
5,475 | 75.90698 | 0 |
male
| 0 | 17 | 509 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 14 | null | 0 | 457,800 | null | null | 25.666656 |
white
| 20.097656 | 15 | 0.765991 | 0.691895 | 2 | 1 | 0 |
yes
| 1 | 0.95 |
no dnr
| 17 | 62 | 12.5 | 65 | 24 | 36.79688 | 260 | null | null | 1.199951 | 136 | 7.529297 | 211 | 23 | 2,470 | 7 | 1 |
no(M2 and SIP pres)
| 1 |
5,476 | 72.93097 | 1 |
male
| 0 | 11 | 223 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 11 |
$11-$25k
| 0 | 20,894 | 12,428.8359 | 10,096 | 21 |
white
| 20.796875 | 32 | 0.827881 | 0.718994 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 11 | 112 | 4.099609 | 105 | 32 | 36.29688 | 330.375 | null | null | 0.699951 | 136 | 7.359375 | 109 | 16 | 1,460 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,477 | 65.40997 | 1 |
male
| 1 | 18 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
>$50k
| 44 | 158,768 | 86,304.1875 | 96,859 | 47.666657 |
white
| 38.59375 | 54 | 0.162994 | 0.080994 | 14 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 16 | 118 | 6.799805 | 65 | 26 | 36.89844 | 112.23438 | null | 0.699951 | 10.798828 | 134 | 7.389648 | 81 | 45 | 1,400 | null | 4 |
<2 mo. follow-up
| 4 |
5,478 | 88.487 | 1 |
female
| 1 | 9 | 9 |
Coma
|
Coma
| 1 | 15 |
under $11k
| 100 | 6,748 | 5,192.2344 | 5,946 | 8 |
white
| 19.597656 | 24 | 0.116989 | 0.071991 | 1 | 0 | 0 |
no
| 0.05 | 0 |
dnr after sadm
| 1 | 48 | 4.299805 | 65 | 24 | 38.09375 | 57 | null | 0.5 | 2.899902 | 140 | 7.30957 | 149 | 30 | 140 | null | 5 |
<2 mo. follow-up
| 5 |
5,479 | 59.75598 | 0 |
male
| 0 | 59 | 509 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 | null | 0 | 287,011 | null | null | 48.75 |
white
| 32.796875 | 52 | 0.635986 | 0.533936 | 3 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 59 | 100 | 10.898438 | 104 | 20 | 37 | null | 3.099609 | 1 | 0.899902 | 133 | null | 102 | 8 | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,480 | 86.50494 | 1 |
female
| 0 | 35 | 150 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$11-$25k
| 0 | 113,600 | 65,823.9375 | 70,361 | 34.75 |
white
| 29 | 37 | 0.61499 | 0.509888 | 1 | 0 | 0 |
no
| 0.4 | 0.3 |
no dnr
| 35 | 46 | 10.099609 | 135 | 38 | 37.79688 | 231.40625 | null | null | 0.5 | 136 | 7.519531 | 103 | 4 | 5,095 | null | null |
adl>=4 (>=5 if sur)
| 2.561523 |
5,481 | 67.87396 | 1 |
male
| 0 | 11 | 172 |
Lung Cancer
|
Cancer
| 1 | 16 |
$25-$50k
| 0 | 17,619 | 10,628.3594 | 11,509 | 13 |
white
| 12.898438 | 30 | 0.774902 | 0.531982 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 11 | 62 | 19.5 | 135 | 40 | 35.59375 | 145 | 2.699707 | 7.599609 | 1.799805 | 135 | 7.479492 | 238 | 43 | 711 | 4 | 5 |
SIP>=30
| 5 |
5,482 | 47.10999 | 0 |
male
| 0 | 27 | 507 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 95,153 | 55,380.75 | 59,054 | 20.5 |
white
| 21.796875 | 41 | 0.859985 | 0.81189 | 4 | 0 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 27 | 58 | 16.699219 | 125 | 47 | 36.19531 | 82.84375 | null | null | 0.899902 | 137 | 7.389648 | 150 | 13 | 694 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,483 | 49.79099 | 0 |
female
| 0 | 6 | 508 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 11 |
under $11k
| 0 | 5,730 | 4,198.6523 | 4,977 | 12 |
white
| 19 | 34 | 0.852905 | 0.756958 | 1 | 1 | 0 |
no
| 0.5 | 0.35 |
no dnr
| 6 | 112 | 8.398438 | 100 | 27 | 38.19531 | 226.65625 | null | null | 0.699951 | 148 | 7.429688 | 118 | 5 | 1,290 | null | 7 |
no(M2 and SIP pres)
| 7 |
5,484 | 79.00299 | 1 |
female
| 0 | 10 | 374 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 8 |
under $11k
| 0 | 22,539 | null | null | 24 |
black
| 15.298828 | 30 | 0.869995 | 0.784912 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 10 | 52 | 0.099991 | 155 | 31 | 38.19531 | 233.3125 | null | 14.898438 | 5.299805 | 141 | 7.339844 | 271 | 98 | 22 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,485 | 68.42999 | 1 |
male
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$25-$50k
| 44 | 664,520 | 39,274.75 | 39,782 | 46 |
white
| 32.695313 | 59 | 0.329956 | 0.214996 | 1 | 0 | 0 |
yes
| 0.6 | 0.6 |
dnr after sadm
| 3 | 52 | 10.099609 | 130 | 32 | 39.79688 | 127.5 | null | 0.899902 | 1.099854 | 131 | 7.5 | 135 | 23 | 3,115 | null | 1 |
<2 mo. follow-up
| 1 |
5,486 | 84.69299 | 1 |
female
| 1 | 9 | 9 |
Coma
|
Coma
| 0 | 8 |
under $11k
| 100 | 15,003 | 9,909.3594 | 9,405 | 17.5 |
white
| 15.898438 | 13 | 0.240997 | 0.175995 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 67 | 0.599976 | 125 | 32 | 39 | 420 | 2.099609 | 4.899414 | 3.399902 | 138 | 7.329102 | 193 | 23 | 290 | null | 0 |
<2 mo. follow-up
| 0 |
5,487 | 65.61798 | 1 |
male
| 0 | 9 | 433 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | 9,071 | 6,422.4492 | 6,518 | 11.5 |
white
| 22.199219 | 18 | 0.733887 | 0.463989 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 9 | 133 | 23 | 115 | 13 | 36.89844 | 304 | 2.099609 | 0.899902 | 6.699219 | 131 | 7.369141 | 102 | 67 | 1,595 | null | 2 |
no(M2 and SIP pres)
| 2 |
5,488 | 25.45099 | 0 |
female
| 0 | 31 | 504 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 17 | null | 44 | 118,800 | 75,492 | 72,145 | 34 |
white
| 39.09375 | 71 | 0.527954 | 0.411987 | 1 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 31 | 55 | 10.599609 | 125 | 9 | 36.69531 | 297.125 | null | 0.899902 | 5.5 | 133 | 7.30957 | 75 | 72 | 0 | null | null |
no(M2 and SIP pres)
| 2.327148 |
5,489 | 70.81195 | 1 |
male
| 0 | 8 | 35 |
Colon Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 13,868 | 8,521.0938 | 8,790 | 6 |
white
| 14 | 14 | 0.844971 | 0.657959 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 8 | 103 | 12 | 60 | 16 | 37.5 | 255 | 2.899902 | 0.599976 | 1 | 140 | 7.40918 | 204 | 2 | 4,960 | 1 | 0 |
<2 mo. follow-up
| 0 |
5,490 | 51.02298 | 0 |
male
| 0 | 6 | 501 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 |
under $11k
| 0 | 22,219 | null | null | 25 |
black
| 24.597656 | 28 | 0.815918 | 0.754883 | 4 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 6 | 97 | 11.599609 | 60 | 20 | 36.69531 | 101.65625 | 4.099609 | 0.699951 | 6.699219 | 134 | 7.329102 | 92 | 46 | 3,205 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,491 | 62.702 | 0 |
male
| 0 | 26 | 501 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 44 | 96,689 | 58,644 | 53,797 | 33.25 |
white
| 16.796875 | 36 | 0.806885 | 0.741943 | 1 | 0 | 0 |
no
| 0.25 | 0.25 |
no dnr
| 26 | 0 | 9.199219 | 0 | 0 | 36 | 76 | 2.099609 | 0.699951 | 1.5 | 138 | 7.279297 | 292 | 11 | 1,640 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,492 | 71.49597 | 1 |
male
| 1 | 23 | 23 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 4 |
under $11k
| 9 | 87,170 | 47,979.6875 | 54,320 | 32.666657 |
white
| 45.59375 | 76 | 0.023998 | 0.006 | 4 | 1 | 0 |
metastatic
| null | null |
dnr after sadm
| 22 | 0 | 9.398438 | 0 | 0 | 38.19531 | 236.65625 | null | null | 0.799927 | 140 | 7.459961 | 142 | 14 | 2,300 | null | 4 |
<2 mo. follow-up
| 4 |
5,493 | 66.98199 | 0 |
male
| 0 | 95 | 498 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | 14 | null | 41 | 373,539 | null | null | 36.5 |
white
| 28.5 | 32 | 0.503906 | 0.302979 | 5 | 1 | 0 |
no
| 0.9 | 0.9 |
dnr after sadm
| 45 | 41 | 13.5 | 0 | 26 | 38.19531 | 137 | null | 2.599609 | 2.599609 | 137 | 6.929688 | 543 | 40 | 140 | null | 6 |
Coma or Intub
| 6 |
5,494 | 64.80499 | 1 |
male
| 0 | 10 | 399 |
Coma
|
Coma
| 1 | null | null | 100 | 25,298 | 15,532.8359 | 16,117 | 25.5 |
white
| 24.296875 | 33 | 0.200989 | 0.140991 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 10 | 65 | 0.099991 | 75 | 25 | 35.59375 | 271.375 | 2.299805 | 1.299805 | 1 | 139 | 7.429688 | 178 | 28 | 2,040 | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
5,495 | 47.27399 | 1 |
female
| 0 | 11 | 177 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 |
under $11k
| 44 | 42,132 | 25,258.0781 | 27,767 | 22 |
white
| 23.199219 | 28 | 0.728882 | 0.644897 | 4 | 0 | 0 |
no
| null | null |
no dnr
| 11 | 167 | 11.699219 | 170 | 24 | 39.59375 | 254.28125 | null | null | 0.5 | 135 | 7.459961 | 136 | 16 | 3,940 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,496 | 58.87698 | 1 |
male
| 1 | 26 | 26 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 60,235 | null | null | 21.5 |
white
| 21.199219 | 23 | 0.866943 | 0.779907 | 1 | 0 | 0 |
no
| 0.85 | 0.75 |
no dnr
| 26 | 115 | 8.099609 | 140 | 10 | 39.09375 | 168.5625 | 3.199707 | 3.099609 | 1.5 | 135 | 7.369141 | 110 | 18 | 2,750 | 5 | 5 |
<2 mo. follow-up
| 5 |
5,497 | 62.40097 | 1 |
male
| 1 | 4 | 4 |
MOSF w/Malig
|
ARF/MOSF
| 2 | null | null | 0 | 21,075 | 12,266.7188 | 12,473 | 33 |
white
| 30.898438 | 48 | 0.454956 | 0.335999 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.3 |
dnr after sadm
| 4 | 72 | 20.796875 | 75 | 9 | 36.79688 | 277.125 | null | null | 1.399902 | 139 | 7.419922 | 199 | 71 | 1,190 | null | null |
<2 mo. follow-up
| 2.602539 |
5,498 | 60.84097 | 0 |
female
| 0 | 28 | 494 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 9 |
$11-$25k
| 9 | 80,127 | null | null | 27 |
white
| 28.5 | 55 | 0.689941 | 0.5979 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 28 | 107 | 12.798828 | 88 | 28 | 36 | 135 | null | null | 0.799927 | 125 | 7.379883 | 149 | 19 | 1,700 | null | 6 | null | 6 |
5,499 | 58.97598 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 41 | 30,892 | 18,894.8906 | 18,901 | 35 |
white
| 24.5 | 44 | 0.679932 | 0.585938 | 2 | 1 | 0 |
no
| 0.8 | 0.8 |
dnr after sadm
| 7 | 112 | 55.898438 | 135 | 37 | 38.79688 | 77 | 1.5 | 3.099609 | 0.599976 | 136 | 7.379883 | 104 | 9 | 1,420 | null | null |
<2 mo. follow-up
| 3.194336 |
5,500 | 81.08698 | 1 |
male
| 1 | 4 | 4 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | null | null | 0 | 20,828 | null | null | 27 |
white
| 26 | 42 | 0.706909 | 0.546997 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 125 | 12.599609 | 155 | 40 | 39.79688 | 316 | 2.299805 | 0.899902 | 0.599976 | 145 | 7.399414 | 229 | 31 | 1,300 | null | null |
<2 mo. follow-up
| 2.28418 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.